Advertisement
IBEX Limited

IBEX Limited (IBEX) Stock Overview

Explore IBEX Limited’s financial performance, market position, analyst ratings, and future outlook.

IBEXNASDAQ
TechnologyInformation Technology Services
$30.08
$0.97(3.33%)
U.S. Market opens in 42h 22m
Advertisement

IBEX Limited (IBEX)

Meyka AI Score

Z

Key Financials

Market Cap402.7M
P/E Ratio8.45
EPS (TTM)$3.55
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$32.41
3 Months$31.02
1 Year Target$41.67

IBEX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IBEX Limited (IBEX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $41.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.45 and a market capitalization of 402.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.33%
5-Day Change
0.53%
1-Month Change
-6.64%
3-Month Change
12.62%
6-Month Change
-21.81%
Year-to-Date (YTD) Change
-21.22%
1-Year Change
4.37%
3-Year Change
42.22%
5-Year Change
48.91%
All-Time (Max) Change
95.32%

Contact Information

202 580 6200
1700 Pennsylvania Avenue NW, Washington, DC, 20006

Company Facts

330,000 Employees
IPO DateAug 7, 2020
CountryUS
Actively Trading

Frequently Asked Questions